Implantable cardioverter-defibrillator therapies in primary prevention are not decreased in a contemporary cohort: insights from long-term follow-up

Back

EHRA Premium Access

Implantable cardioverter-defibrillator therapies in primary prevention are not decreased in a contemporary cohort: insights from long-term follow-up

Session: Implantable cardioverter-defibrillator therapy

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor I. Ferreira Neves (Lisboa, PT)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Ines Ferreira Neves

Centro Hospitalar Universitario de Lisboa Central, E.P.E., Lisboa (Portugal)

4 presentations

0 follower

6 more presentations in this session

Comparison of newly detected atrial high-rate episodes incidence in single-lead ICDs with a floating atrial dipole and dual-chamber ICDs: a propensity score-matched analysis from the HMEA project

Speaker: Doctor G. Mitacchione (Brescia, IT)

Single- versus dual-chamber ICD discriminators for tachyarrhythmia detection: a remote monitoring based, single-center study

Speaker: Doctor F. Gausz (Szeged, HU)

In silico modeling of cardiac defibrillation with novel deep septal ICD leads

Speaker: Doctor G. Imnadze (Bad Oeynhausen, DE)

Adoption of consensus-based tachycardia detection ICD programming in clinical practice: a national cohort study

Speaker: Doctor P. Pieragnoli (Florence, IT)

Evaluating subcutaneous implantable cardioverter defibrillators in hypertrophic cardiomyopathy: fewer complications without increased therapies

Speaker: Mr C. Monkhouse (London, GB)

Access the full session

Implantable cardioverter-defibrillator therapy

Speakers: Doctor I. Ferreira Neves, Doctor G. Mitacchione, Doctor F. Gausz, Doctor G. Imnadze, Doctor P. Pieragnoli...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources